VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback